6505-13-119-8648
Sodium Hyaluronate Injection
6505131198648 131198648 SUPARTZ INJ. 1 X 2.5ML - 1% SUPARTZ INJECTION 1X25MG SUPARTZ INJ. 25MG - 1 X 2.5 ML 1542935
INC: 35854 Sodium Hyaluronate Injection
Managed by Belgium
NSN Created on 16 Jul 2007
Data Last Changed
January 2023
January 2023
NATO Update Count
1
1
NATO Data Quality
Marketplace 6505-13-119-8648
Need Help?
Request a Quotation from participating marketplace vendors
Request a Quotation from participating marketplace vendors
Related Documents 6505-13-119-8648 1+ Documents (More...)
SUPARTZ INJ. 1 X 2.5ML - 1% SUPARTZ INJECTION 1X25MG SUPARTZ INJ. 25MG - 1 X 2.5 ML 1542935 Managed
RQST NE Updated Every Day 6505-13-119-8648 RQST Updated Every Day 6505-13-119-8648 RQST NE Related Documents
6505-13-119-8648 1+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/be 6505-13-119-8648
RQST NE Updated Every Day 6505-13-119-8648 RQST Updated Every Day 6505-13-119-8648 RQST NE Related Documents
6505-13-119-8648 1+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/be 6505-13-119-8648
Restrictions 6505-13-119-8648
End Users 6505-13-119-8648
- Belgium (ZB)
Approved Sources 6505-13-119-8648
- Part Number
- Manufacturer
- Status
- SUPARTZ INJ. 1 X 2.5ML - 1%
- Manufacturer
- SP489 - Seikagaku Corp. (Replaced)
- Primary Buy
- Primary Buy
- SUPARTZ INJECTION 1X25MG
- B1707 - Astrazeneca (Active)
- Secondary Buy
- Secondary Buy
- SUPARTZ INJ. 25MG - 1 X 2.5 ML
- B2651 - Smith & Nephew (Active)
- Secondary Buy
- Secondary Buy
- 1542935
- B6095 - Association Pharmaceutique (Active)
- Secondary Buy
- Secondary Buy
Similar Supply Items to 6505-13-119-8648
